Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
复制标题
DOI：
10.1111/dom.14062
复制
发表时间：
2020-05-19
影响因子：
5.8
通讯作者：
Khunti, Kamlesh
中科院分区：
文献类型：
--
作者：
Khunti, Sachin;Khunti, Nitisha;Khunti, Kamlesh
世界卫生组织已宣布严重急性呼吸综合征冠状病毒 2（SARS-CoV-2 或 COVID-19）为大流行病，并促使所有国家争先恐后地审查紧急医疗保健规定。全球证据表明，每个国家都在努力有效管理被诊断出感染该病毒的人数。这是近几代人以来从未经历过的考验时期，并且对于 COVID-19 和心脏代谢疾病患者的管理存在许多不安全感。这篇综述强调了当前与 COVID-19 相关的担忧，并就治疗的不确定性和在管理患者时与治疗相关的潜在不利危害提供了建议，特别是那些患有心脏代谢疾病、感染了 COVID-19 或感染风险增加的患者。
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) has been declared a pandemic by the World Health Organization and sent all countries scrambling to review emergency healthcare provisions. There is global evidence of each nation struggling to effectively manage the number of people being diagnosed with the virus. These are testing times which have not been experienced in recent generations and there are a number of insecurities regarding the management of people with COVID-19 and cardiometabolic diseases. This review highlights the current concerns related to COVID-19 and provides advice in terms of the therapeutic uncertainty and potential adverse harms associated with therapy when managing people, particularly those with cardiometabolic diseases, who have contracted or are at increased risk of contracting COVID-19.